Organigram eyes global cannabis growth after Motif deal

Wed, Dec 18

Key Points

Organigram Holdings is expanding its focus beyond Canada's borders after completing its biggest deal yet. Executives shared plans to further penetrate Germany's medical market and capitalize on the recent acquisition of Motif Labs.
The company aims to increase its international presence, targeting key markets like Germany where medical cannabis demand is growing.
Organigram is leveraging its recent acquisition of Motif Labs to enhance its product offerings and drive growth in the cannabis industry.
The company's executives expressed optimism about the potential opportunities for expansion and value creation in the global cannabis market.

Fresh off its biggest deal yet, Organigram Holdings (Nasdaq: OGI) is now refocusing its attention beyond Canada’s borders.

The cannabis producer’s executives painted an ambitious picture during Wednesday’s earnings call, detailing plans to dive deeper into Germany’s medical market while squeezing more value from their recent Motif Labs purchase.

“There’s lots of...

Please login to read all 487 words.

Discover